[1] |
Sorrow JM Jr, Hitch JM. Dyskeratosis congenita. First report of its occurrence in a female and a review of the literature[J]. Arch Dermatol, 1963,88:340⁃347. doi: 10.1001/archderm.1963.01590 210098015.
|
[2] |
Sirinavin C, Trowbridge AA. Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature[J]. J Med Genet, 1975,12(4):339⁃354. doi: 10. 1136/jmg.12.4.339.
|
[3] |
Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders[J]. Expert Rev Hematol, 2013,6(3):327⁃337. doi: 10.1586/ehm. 13.23.
|
[4] |
Glousker G, Touzot F, Revy P, et al. Unraveling the pathogenesis of Hoyeraal⁃Hreidarsson syndrome, a complex telomere biology disorder[J]. Br J Haematol, 2015,170(4):457⁃471. doi: 10.1111/bjh.13442.
|
[5] |
Elliott AM, Graham GE, Bernstein M, et al. Dyskeratosis congenita: an autosomal recessive variant[J]. Am J Med Genet, 1999,83(3):178⁃182. doi: 10.1002/(sici)1096⁃8628(19990319) 83:33.0.co;2⁃3.
|
[6] |
Drachtman RA, Alter BP. Dyskeratosis congenita[J]. Dermatol Clin, 1995,13(1):33⁃39.
|
[7] |
Walne AJ, Vulliamy T, Beswick R, et al. Mutations in C16orf57 and normal⁃length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund⁃Thomson syndrome[J]. Hum Mol Genet, 2010,19(22):4453⁃4461. doi: 10.1093/hmg/ddq371.
|
[8] |
Diaz de Leon A, Cronkhite JT, Katzenstein AL, et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations[J/OL]. PLoS One, 2010,5(5):e10680. doi: 10.1371/journal.pone. 0010680.
|
[9] |
Pestana A, Vinagre J, Sobrinho⁃Simões M, et al. TERT biology and function in cancer: beyond immortalisation[J]. J Mol Endocrinol, 2017,58(2):R129⁃R146. doi: 10.1530/JME⁃16⁃0195.
|
[10] |
Imamura S, Uchiyama J, Koshimizu E, et al. A non⁃canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesis[J/OL]. PLoS One, 2008,3(10):e3364. doi: 10.1371/journal.pone.0003364.
|
[11] |
Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult⁃onset pulmonary fibrosis caused by mutations in telomerase[J]. Proc Natl Acad Sci U S A, 2007,104(18):7552⁃7557. doi: 10.1073/pnas.0701 009104.
|
[12] |
Du HY, Pumbo E, Manley P, et al. Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene[J]. Blood, 2008,111(3):1128⁃1130. doi: 10.1182/blood⁃2007⁃10⁃120907.
|
[13] |
Walne AJ, Vulliamy T, Kirwan M, et al. Constitutional mutations in RTEL1 cause severe dyskeratosis congenita[J]. Am J Hum Genet, 2013,92(3):448⁃453. doi: 10.1016/j.ajhg.2013.02.001.
|
[14] |
Batista LF, Pech MF, Zhong FL, et al. Telomere shortening and loss of self⁃renewal in dyskeratosis congenita induced pluripotent stem cells[J]. Nature, 2011,474(7351):399⁃402. doi: 10.1038/nature10084.
|
[15] |
Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia[J]. N Engl J Med, 2005,352(14):1413⁃1424. doi: 10.1056/NEJMoa 042980.
|
[16] |
Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders[J]. Expert Rev Hematol, 2013,6(3):327⁃337. doi: 10.1586/ehm. 13.23.
|
[17] |
Walne AJ, Vulliamy T, Beswick R, et al. Mutations in C16orf57 and normal⁃length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund⁃Thomson syndrome[J]. Hum Mol Genet, 2010,19(22):4453⁃4461. doi: 10.1093/hmg/ddq371.
|
[18] |
Youssefian L, Vahidnezhad H, Barzegar M, et al. The Kindler syndrome: a spectrum of FERMT1 mutations in Iranian families[J]. J Invest Dermatol, 2015,135(5):1447⁃1450. doi: 10.1038/jid.2015.9.
|
[19] |
German J, Sanz MM, Ciocci S, et al. Syndrome⁃causing mutations of the BLM gene in persons in the Bloom′s Syndrome Registry[J]. Hum Mutat, 2007,28(8):743⁃753. doi: 10.1002/humu.20501.
|
[20] |
Zhang Z, Zhang J, Chen F, et al. Family of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis caused by a novel FAM111B mutation[J]. J Dermatol, 2019,46(11):1014⁃1018. doi: 10.1111/1346⁃8138.15045.
|
[21] |
Saijo M, Takedachi A, Tanaka K. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA[J]. J Biol Chem, 2011,286(7):5476⁃5483. doi: 10.1074/jbc.M110.172916.
|
[22] |
Ogden GR, Connor E, Chisholm DM. Dyskeratosis congenita: report of a case and review of the literature[J]. Oral Surg Oral Med Oral Pathol, 1988,65(5):586⁃591. doi: 10.1016/0030⁃4220(88)90142⁃9.
|
[23] |
Nelson AS, Marsh RA, Myers KC, et al. A reduced⁃intensity conditioning regimen for patients with dyskeratosis congenita undergoing hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2016,22(5):884⁃888. doi: 10.1016/j.bbmt.2016.01.026.
|
[24] |
Li F, Li W, Qiao X, et al. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review[J]. Int J Hematol, 2019,109(3):328⁃335. doi: 10.1007/s12185⁃018⁃02582⁃x.
|